Mechanistic description
The debate supports carrying forward TREM2 enhancement as a way to restore protective microglial response and reduce downstream tau spread only if a proximal endpoint changes before the late outcome. The decisive validation path is: stage-stratified TREM2 gain-of-function perturbation with microglial lipid handling, plaque compaction, and tau propagation endpoints.
Mechanism / pathway
- TREM2
- neurodegeneration
Evidence for (1)
Preregistered claim: TREM2 enhancement reduces microglial dysfunction and downstream tau pathology, slowing AD progression
Evidence against (1)
TREM2 activation can be stage-dependent and may worsen inflammatory injury outside the right disease window
Evidence matrix
Supporting
- Preregistered claim: TREM2 enhancement reduces microglial dysfunction and downstream tau pathology, slowing AD progression AD-MASTER-PLAN-TREM2-20260428030753
Contradicting
- TREM2 activation can be stage-dependent and may worsen inflammatory injury outside the right disease window AD-MASTER-PLAN-TREM2-20260428030753
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). TREM2 enhancement as a way to restore protective microglial response and reduce…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-c843352776
@misc{scidex_hypothesis_hc843352,
title = {TREM2 enhancement as a way to restore protective microglial response and reduce…},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-c843352776},
note = {SciDEX artifact hypothesis:h-c843352776}
}